Ventilator Associated Pneumonia
Conditions
Keywords
VAP
Brief summary
Ventilator Associated Pneumonia (VAP) is a common complication experienced by mechanically ventilated patients and within the framework of Respiratory Intensive Care Units. The AnapnoGuard system, developed by Hospitech Respiration Ltd. is a ventilation guard system that includes a number of unique characteristics. This study was designed to test the frequency VAP in mechanically ventilated ICU patients using the AnapnoGuard System.
Interventions
DEVICEAnapnoGuard 100,
Respiratory guard system during mechanical ventilation with routine mechanical ventilator
DEVICEroutine mechanical ventilator
routine mechanical ventilation
Sponsors
Hospitech Respiration
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* ICU patients; * Patient was connected to AnapnoGuard system up to six hours from intubation; * Age - above 18.
Exclusion criteria
* Pneumonia; * Aspiration Pneumonia; * Chronic or Severe Pneumonia; * Chronic Obstructive Pulmonary Disease (COPD) requiring permanent home-based antibiotic treatment; * Interstitial Lung Disease (ILD); * Post Lung Transplant State; * Immunosuppression. * Patients ventilated in prone position * Patient who was ventilated 3 months prior to being enrolled in the study * Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAP occurence | 2 years |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events occurence | 2 years |
Countries
Israel
Outcome results
None listed